NRC Stock Analysis: Buy, Sell, or Hold?
NRC - National Research Corporation Common Stock (Delaware)
$20.81
0.27 (1.31%)
▲
5d:
+12.24%
30d:
+8.78%
90d:
+18.78%
BUY
MODERATE Confidence
Analysis Updated: Jun 26, 2026 12:00 AM ET
Earnings: Jul 27, 2026
28d
Get Alerted When NRC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: NRC shows positive signals but monitor for confirmation. Market pricing in 0.3% growth. Moderate conviction.
💡 BUY OPPORTUNITY: NRC shows positive signals but monitor for confirmation. Market pricing in 0.3% growth. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$40.21
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$24.97
16.7% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 19.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: NRC is currently trading at $20.81, which is considered extended relative to its 30-day fair value range of $18.62 to $20.23. The stock's valuation (Forward PE: 19.4) is in line with its historical norms (19.3). At these levels, the market is pricing in 0.3% annual earnings growth.
Technical Outlook: Technically, NRC is in a uptrend. The price is approaching resistance at $20.51. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: NRC has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $23.00 (+10.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, NRC is in a uptrend. The price is approaching resistance at $20.51. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: NRC has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $23.00 (+10.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$18.62 -
$20.23
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
62.9%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($23.00)
- BULLISH: Expecting earnings turnaround to 0.3% growth with 3.7% revenue growth
Trading Range Analysis
30-Day Trading Range
$18.62 -
$20.23
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$18.77
Resistance Level
$20.51
Current Trend
Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
19.45
Wall Street Target
$23.00
(+10.5%)
Revenue Growth (YoY)
3.7%
Earnings Growth (YoY)
-44.0%
Profit Margin
6.5%
Valuation Premium vs History
+0.3% premium
PE vs Historical
19.5 vs 19.3
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.3%
(market-implied from PE analysis)
1-Year Target
$20.87
(+0%)
2-Year Target
$20.94
(+1%)
3-Year Target
$21.00
(+1%)
3-Yr Target (if PE normalizes)
(PE: 19→19)
PE COMPRESSION
$20.84
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 214.7%)
$78.65
(+278%)
Base:
(SPY PE: 19.4, Growth: 214.7%)
$70.23
(+238%)
Bear:
(PE: 16.5, Growth: 214.7%)
$59.70
(+187%)
📈
Valuation based on Current Earnings
Forward PE: 17.21 | Forward EPS (Implied): $1.21
Bull Case
$25.13
(+21%)
Analyst growth 15.0%, PE expands to 18.1
Base Case
$20.81
(0%)
Market implied 0.0%, PE stable at 17.2
Bear Case
$15.92
(-24%)
Severe decline -15.0%, PE contracts to 15.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: June 28, 2026 6:43 PM ET
Data refreshes hourly during market hours. Next update: 7:43 PM
Data refreshes hourly during market hours. Next update: 7:43 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NRC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$245 | 57 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$31 | 51 HOLD |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 66 BUY |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 58 HOLD |
|
EVH
Evolent Health Inc |
STRONG BUY
14 analysts |
$6 | 62 BUY |
